COPD Seven (US, France, Germany, Italy, Spain, UK, Japan) Drug Market Analysis & Forecasts 2024: Sales to Reach $30.8 Billion in 2033 - GSK, AstraZeneca, and Sanofi/Regeneron Compete for First Place
11. Oktober 2024 06:35 ET
|
Research and Markets
Dublin, Oct. 11, 2024 (GLOBE NEWSWIRE) -- The "COPD: Seven-Market Drug Forecast and Market Analysis" report has been added to ResearchAndMarkets.com's offering.This report covers the 7MM (US,...
Chronic Obstructive Pulmonary Disease (COPD) Epidemiology Forecast to 2033: Focus on US, France, Germany, Italy, Spain, UK, and Japan
13. September 2024 06:56 ET
|
Research and Markets
Dublin, Sept. 13, 2024 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease (COPD): Epidemiology Forecast to 2033" report has been added to ResearchAndMarkets.com's offering. In the...
Chronic Obstructive Pulmonary Disease (COPD) Global Clinical Trials Review, 2023: High-Level Data, Leading Companies, Trial Outcomes, Enrollment Trends, and Latest Developments
25. Januar 2024 08:19 ET
|
Research and Markets
Dublin, Jan. 25, 2024 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease (COPD) - Global Clinical Trials Review, 2023" report has been added to ResearchAndMarkets.com's offering. This...
Global Chronic Obstructive Pulmonary Disease Therapeutics Market 2023-2028: AstraZeneca, Boehringer Ingelheim, and Novartis Spearhead Advancements
31. August 2023 06:24 ET
|
Research and Markets
Dublin, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The "Global Chronic Obstructive Pulmonary Disease Therapeutics Market (2023-2028) by Drug Type, Distribution Channel, and Geography, Competitive Analysis,...
Global Chronic Obstructive Pulmonary Disease Therapeutics Market 2023-2028: AstraZeneca, Boehringer Ingelheim, and Novartis Spearhead Advancements
31. August 2023 06:22 ET
|
Research and Markets
Dublin, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The "Global Chronic Obstructive Pulmonary Disease Therapeutics Market (2023-2028) by Drug Type, Distribution Channel, and Geography, Competitive Analysis,...
Global Chronic Obstructive Pulmonary Disease Therapeutics Market 2023-2028: AstraZeneca, Boehringer Ingelheim, and Novartis Spearhead Advancements
31. August 2023 06:19 ET
|
Research and Markets
Dublin, Aug. 31, 2023 (GLOBE NEWSWIRE) -- The "Global Chronic Obstructive Pulmonary Disease Therapeutics Market (2023-2028) by Drug Type, Distribution Channel, and Geography, Competitive Analysis,...
Global Chronic Obstructive Pulmonary Disease (COPD) Market Report 2023 - 2028: Featuring AstraZeneca, Pfizer, GlazoSmithKline and Novartis Among Others
23. Januar 2023 10:03 ET
|
Research and Markets
Dublin, Jan. 23, 2023 (GLOBE NEWSWIRE) -- The "Chronic Obstructive Pulmonary Disease (COPD) Market, Global Forecast 2023-2028, Industry Trends, Growth, Insight, Impact of Inflation, Company...